Prosecution Insights
Last updated: October 27, 2026

Theodore Charles Striegel, USPTO Patent Examiner

Listed by the USPTO as STRIEGEL, THEODORE CHARLES

Tech Center 2100 • Art Units: 1671 1677 1685 2127 2141

This examiner grants 22% of resolved cases

Analysis

STRIEGEL, THEODORE CHARLES is assigned to tech center 2100 and art unit 1671. The record includes 64 resolved cases, an allowance rate of 21.9%, and a median of 1652 days to allowance. The allowance result indicates that successful outcomes are less frequent in the available record, and the median points to a prolonged prosecution timeline. The limited case volume makes file-specific review especially important.

The interview lift is 23.6%, suggesting that interviews may provide a useful channel for addressing examination issues even though the overall allowance rate is low. The listed companies are 10x Genomics Inc., Boston Scientific Corporation, and BOE Technology Group Co., Ltd. Calfee, Halter & Griswold LLP, FISH & RICHARDSON P.C. (TC), and POLSINELLI PC (Main Customer Number) are the listed firms.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

21.9%
Allow Rate
-33.1% vs TC avg
90
Total Applications
+23.6%
Interview Lift
1652
Avg Prosecution Days
Based on 64 resolved cases, 2023–2026

Rejection Statute Breakdown

28.3%
§101 Eligibility
5.1%
§102 Novelty
32.8%
§103 Obviousness
23.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18362382 MEDICAL DEVICE SYSTEM FOR CLASSIFICATION AND PREDICTION OF MEDICAL EVENTS USING TIME-BETWEEN-EVENT VALUES Non-Final OA Boston Scientific Scimed, Inc.
18264254 RNA-PROTEIN INTERACTION PREDICTION METHOD AND APPARATUS, AND MEDIUM AND ELECTRONIC DEVICE Non-Final OA BOE Technology Group Co., Ltd.
18453735 METHOD FOR EPITOPE BINNING OF NOVEL MONOCLONAL ANTIBODIES Non-Final OA 10x Genomics, Inc.
16951864 PIPELINE FOR SPATIAL ANALYSIS OF ANALYTES Final Rejection 10X Genomics, Inc.
18250140 SYSTEMS AND METHODS FOR QUANTIFYING PATIENT IMPROVEMENT THROUGH ARTIFICIAL INTELLIGENCE Non-Final OA Northwestern University
18029550 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID Non-Final OA Claret Bioscience, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Theodore Charles Striegel's allowance rate?

21.9% of resolved applications examined by Theodore Charles Striegel were allowed (64 resolved cases), compared with 39.7% across Art Unit 1671 over the last five years.

Does an interview help with examiner Theodore Charles Striegel?

This examiner's interview lift is +23.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Theodore Charles Striegel take to allow a patent?

Applications allowed by Theodore Charles Striegel took 1,652 days on average from filing to allowance.

Which art unit does examiner Theodore Charles Striegel work in?

Theodore Charles Striegel examines applications in Art Unit 1671 in Tech Center 2100 (Computing & Software).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month